NBS

Neostem, Inc. News Headlines

$3.36
*  
0.09
2.75%
Get NBS Alerts
*Delayed - data as of Dec. 26, 2014 10:50 ET  -  Find a broker to begin trading NBS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    NBS Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Is There Investment Upside In The Future Of Treating Diabetes?
2/10/2014 8:01:00 AM - Seeking Alpha


Contract Manufacturing: Often Ignored, But Potentially Profitable
2/3/2014 12:04:00 PM - Seeking Alpha


A Comprehensive Look At Athersys
2/3/2014 10:12:00 AM - Seeking Alpha


Cramer's Mad Money - 11 Earnings To Watch In The Week Ahead (1/31/14)
2/2/2014 6:41:00 AM - Seeking Alpha


Could PCT Be NeoStem's Breakout Star?
1/27/2014 12:06:00 PM - Seeking Alpha


Clearing Up Misconceptions About NeoStem's AMR-001
1/22/2014 12:52:00 PM - Seeking Alpha


ThermoGenesis Merging With TotiRx - Heating Up Cell Therapy Mergers And Acquisitions
1/21/2014 3:33:00 PM - Seeking Alpha


3 Small Biotech Companies Poised For Big Growth In 2014
1/21/2014 1:07:00 PM - Seeking Alpha


Neostem Could Rally On Phase II Results
1/8/2014 5:36:00 AM - Seeking Alpha


4 Stocks That Could See Significant Gains In 2014
1/6/2014 2:35:00 PM - Seeking Alpha


Cellular Therapy: Representing The Paradigm Shift In Healthcare
12/31/2013 8:50:00 AM - Seeking Alpha


Who Will Win The Stem Cell Race?
12/24/2013 6:47:00 AM - Seeking Alpha


Neostem Stands To Benefit From Stem-Cell Deals
12/23/2013 9:20:00 AM - Seeking Alpha


NeoStem: Continued Progress And 2014 Catalysts
12/19/2013 2:33:00 PM - Seeking Alpha


Why Is Complete Enrollment Important To NeoStem Investors?
12/17/2013 5:27:00 AM - Seeking Alpha


Sector Update: Healthcare Shares Flat to Lower; Lexicon Drops 13% on Phase 2 Study of IBS Treatment
12/3/2013 8:27:53 AM - MT Newswires


Sector Update: Healthcare
12/3/2013 8:24:34 AM - MT Newswires


NeoStem: Major Developments You Might Have Missed
10/30/2013 8:00:00 AM - Seeking Alpha


NeoStem: Catalysts Upcoming, Financing In Rear View Mirror
10/28/2013 2:43:00 PM - Seeking Alpha


Celgene And NeoStem: 2 Biopharmaceutical Companies Poised For Growth
10/21/2013 12:33:00 PM - Seeking Alpha


Stem Cell Therapy: Coming Into Maturity And Becoming Medical Reality
10/18/2013 10:16:00 AM - Seeking Alpha


This Short-Term Pain Might Be Best For Long-Term Gain
10/15/2013 3:01:00 AM - Seeking Alpha


NeoStem, Inc. Robin L. Smith, M.D., MBA - Chairman and CEO Signature Series
10/14/2013 5:05:23 PM - Nasdaq CEO Signature Series


Companies Race To Develop The Next Novel Blockbuster Diabetes Drug - Part 2
10/6/2013 5:12:00 AM - Seeking Alpha


NeoStem: An Investment In 4 Different Divisions
9/30/2013 8:23:00 AM - Seeking Alpha